|
|
||||||||||
|
J Am Coll Cardiol, 2000; 36:1104-1109 © 2000 by the American College of Cardiology Foundation |



* Division of Cardiology, St. Pauls Hospital, Vancouver, British Columbia, Canada
Division of Cardiovascular Surgery, St. Pauls Hospital, Vancouver, British Columbia, Canada
Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Division of Cardiac Imaging, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
|| New England Research Institutes, Watertown, Massachusetts, USA
¶ Division of Cardiology, St. LukesRoosevelt Hospital Center and Columbia University, New York, New York, USA
Reprint requests and correspondence: Dr. C.R. Thompson, Director, Cardiology Clinical Research, St. Pauls Hospital, Room 5134-1081 Burrard Street, Vancouver, B.C., Canada V6Z 1Y6
cthompson{at}Providencehealth.bc.ca
OBJECTIVES
Our objective was to define the outcomes of patients with cardiogenic shock (CS) due to severe mitral regurgitation (MR) complicating acute myocardial infarction (AMI).
BACKGROUND
Methods for early identification and optimal treatment of such patients have not been defined.
METHODS
The SHOCK Trial Registry enrolled 1,190 patients with CS complicating AMI. We compared 1) the cohort with severe mitral regurgitation (MR, n = 98) to the cohort with predominant left ventricular failure (LVF, n = 879), and 2) the MR patients who underwent valve surgery (n = 43) to those who did not (n = 51).
RESULTS
Shock developed early after MI in both the MR (median 12.8 h) and LVF (median 6.2 h) cohorts. The MR patients were more often female (52% vs. 37%, p = 0.004) and less likely to have ST elevation at shock diagnosis (41% vs. 63%, p < 0.001). The MR index MI was more frequently inferior (55% vs. 44%, p = 0.039) or posterior (32% vs. 17%, p = 0.002) than that of LVF and much less frequently anterior (34% vs. 59%, p < 0.001). Despite having higher mean LVEF (0.37 vs. 0.30, p = 0.001) the MR cohort had similar in-hospital mortality (55% vs. 61%, p = 0.277). The majority of MR patients did not undergo mitral valve surgery. Those undergoing surgery exhibited higher mean LVEF than those not undergoing surgery; nevertheless, 39% died in hospital.
CONCLUSIONS
The data highlight opportunities for early identification and intervention to potentially decrease the devastating mortality and morbidity of severe post-myocardial infarction MR.
| ||||||||||||||||||||
This article has been cited by other articles:
![]() |
R. Lorusso, S. Gelsomino, G. De Cicco, C. Beghi, C. Russo, M. De Bonis, A. Colli, and A. Sala Mitral valve surgery in emergency for severe acute regurgitation: analysis of postoperative results from a multicentre study Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 573 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Alexander, L. K. Newby, P. W. Armstrong, C. P. Cannon, W. B. Gibler, M. W. Rich, F. Van de Werf, H. D. White, W. D. Weaver, M. D. Naylor, et al. Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology Circulation, May 15, 2007; 115(19): 2570 - 2589. [Abstract] [Full Text] [PDF] |
||||
![]() |
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology Eur. Heart J., February 2, 2005; 26(4): 384 - 416. [Full Text] [PDF] |
||||
![]() |
P. Chevalier, H. Burri, F. Fahrat, M. Cucherat, O. Jegaden, J.-F. Obadia, G. Kirkorian, and P. Touboul Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Pellizzon, C. L. Grines, D. A. Cox, T. Stuckey, J. E. Tcheng, E. Garcia, G. Guagliumi, M. Turco, A. J. Lansky, J. J. Griffin, et al. Importance of mitral regurgitation inpatients undergoing percutaneous coronaryintervention for acute myocardial infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1368 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Braun, P.G. Voigt, M.I.M. Versteegh, and R.A.E. Dion Restrictive mitral annuloplasty in refractory cardiogenic shock with acute postinfarction mitral insufficiency and intact papillary muscle J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 284 - 286. [Full Text] [PDF] |
||||
![]() |
S. C. Wong, T. Sanborn, L. A. Sleeper, J. G. Webb, R. Pilchik, D. Hart, S. Mejnartowicz, T. A. Antonelli, R. Lange, J. K. French, et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |